Sarah B. Noonberg

This profile gathers the share dealings of Sarah B. Noonberg across 3 companies, led by Protagonist Therapeutics, Inc, Marinus Pharmaceuticals, Inc. and Metagenomi Therapeutics, Inc. We count 11 filings; the first trade dates from 10 February 2021 and the latest from 6 June 2025.

On the market, this insider has only sold: 4 sales, €183k in total. Other entries cover 7 share grants. So far in 2025, the count stands at no purchases and 1 sale.

On 9 June 2025 came the latest disclosure, an open-market sale for €8,005 in Metagenomi Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.